In an effort to make Dr. Plant to the top cosmetics brand in China, the company has agreed to a post-investment management and strategic cooperation in cross-border integration with Fosun Capital.
With sales increasing more than 50% and ownership of more than 2,200 single-brand stores, Dr. Plant is a company on the rise. “The capacity and personality of leaders is the key criterion when selecting enterprises,” said Wang Zhou, Dr. Plant’s new strategic investor, “Leaders must have vision and ambition.” Dr. Plant currently plans a global concept store in Shanghai Tower.
“We will cooperate with our financiers on the integration of overseas resources and international brand acquisition,” said Xie Young, founder of Dr. Plant.
